NCT04082520
- Conditions
- Central Nervous System Neoplasms, Grade 1 Meningioma, Grade 2 Meningioma, +12 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
Grade 3 Meningioma
Explore clinical trials studying Grade 3 Meningioma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Grade 3 Meningioma trial results
Active, Not Recruiting
Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
NCT03604978
- Conditions
- Central Nervous System Neoplasms, Grade 2 Meningioma, Grade 3 Meningioma, +10 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States